Skip to main content
SpringerLink
Log in

Cancer drug prices vary between high-income countries

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vogler S, et al. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet Oncology : 4 Dec 2015. Available from: URL: http://dx.doi.org/10.1016/S1470-2045(15)00449-0

    Google Scholar 

  2. van Harten WH, et al. Actual costs of cancer drugs in 15 European countries. Lancet Oncology : 4 Dec 2015. Available from: URL: http://dx.doi.org/10.1016/S1470-2045(15)00486-6

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cancer drug prices vary between high-income countries. PharmacoEcon Outcomes News 743, 17 (2015). https://doi.org/10.1007/s40274-015-2682-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2682-9

Search

Navigation